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Abstract
Myelin proteolipid protein (PLP) 139–151 is an immunodominant peptide that induces experimental
autoimmune encephalomyelitis (EAE) in H-2s SJL/J mice. While PLP 139–151-specific TCR transgenic
(tg) 4E3 mice develop fulminant spontaneous disease on the susceptible SJL/J background,
spontaneous EAE is dramatically reduced on the H-2s congenic B10.S background. On this resistant
background, we observed a high frequency of positively selected tg CD42CD82 (DN) thymocytes and
peripheral DN tg T cells. Splenic DN tg T cells responded to anti-CD3 stimulation similarly to CD41
cells, but proliferative and cytokine responses to PLP 139–151 were blunted, implying that CD4 coreceptor down-regulation modulated T cell responses to the self-antigen in vitro. Adoptive transfer of
tg DN CD3hi cells into RAG-deficient wild-type (WT) recipients induced EAE less efficiently than
transfer of CD41 T tg cells indicating the blunted responses of DN tg T cells to self-antigen in vivo.
The frequency of tg DN T cells was irrespective of thymic expression of the autoantigen. These data
implicate that down-regulation of CD4 co-receptor in the thymus, which is independent from the
expression of thymic autoantigen, results in a blunted response to the autoantigen in the periphery
and limits the incidence of spontaneous autoimmunity in genetically resistant mice bearing a large
autoreactive tg T cell repertoire.

Introduction
The immune system has evolved to combat pathogens,
while maintaining tolerance to self-antigens. Although T cells
capable of recognizing self-antigens are present in healthy
subjects, autoimmune disease does not occur in most individuals. How this tolerance is achieved is fundamental to understanding tolerance and development of autoimmune
reactions. During development, thymocytes bearing selfreactive TCRs are clonally deleted in the thymus by negative
selection (1). In addition to physical elimination, modulation
of TCR expression and functional inactivation (anergy) are
believed to inactivate highly autoreactive thymocytes (2, 3).
Although central tolerance is important for averting autoimmunity, it does not completely prevent the generation of lowaffinity self-reactive T cells, which escape thymic deletion

and are exported to the peripheral immune compartment
(4–6). Since TCRs are inherently cross-reactive and the activation threshold of memory T cells is lower (7), additional
mechanisms in the periphery inhibit the activation of autoreactive T cells to ensure maintenance of self-tolerance. Induction of regulatory/suppressor T cells, ignorance to the
self-antigen (8–10), down-regulation of the TCR (11), functional unresponsiveness of T cells (12–16), altered response
to cross-reactive ligands (17) and the complete elimination
of autoreactive T cell clones from the peripheral repertoire
(18, 19) are the mechanisms involved in the maintenance of
tolerance against self in the periphery. Modulation of expression of co-receptors on thymocytes or peripheral T cells can
contribute to self-tolerance to positively selecting ligands,
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a process that is probably related to the affinity of TCR to
the selecting ligand (20–22). We have also shown downregulation of the CD4 co-receptor on peripheral T cells in response to repeated stimulation with high-affinity heteroclitic
ligand in vitro, and this co-receptor down-modulation
resulted in an increase in the activation threshold of the
responding T cells (23).
Myelin proteolipid protein (PLP) is the major protein of
central nervous system (CNS) myelin. PLP 139–151 is the
dominant epitope that induces experimental autoimmune encephalomyelitis (EAE) in SJL/J (H-2s) mice. In contrast,
B10.S mice are relatively resistant to EAE induction by PLP
139–151 immunization, even though both strains carry the
same H-2s MHC II molecules (24–26). We previously generated different lines of transgenic (tg) mice that express rearranged abTCR specific to PLP 139–151 (27). When one of
the tg lines (4E3) was backcrossed onto the EAE-susceptible
SJL/J background, the mice developed spontaneous fulminant disease with such a high frequency that the line
could not be maintained (27). We have now fully backcrossed this line onto the EAE-resistant B10.S background
and observed a significantly reduced frequency and severity of
spontaneous disease. Our data suggest that down-regulation
of the CD4 co-receptor appears to be responsible for the
increased number of double-negative (DN) tg T cells serving
as one of the mechanisms utilized by autoreactive T cells to
prevent development of autoimmune disease on the resistant B10.S background. Our data further show that this process may be independent of the level of PLP expression in
the thymus of B10.S mice.
Methods

Diego, CA, USA). The cells were stained in PBS with 2%
BSA (Sigma, St Louis, MO, USA) and acquired by FACSort
flow cytometer (Becton Dickinson, San Jose, CA, USA). The
data were analyzed by FlowJo software (Tree Star, Ashland,
OR, USA).
Cell sorting
To analyze in vitro T cell responses and to transfer T cell subsets into RAG2-deficient B10.S hosts, splenocytes or thymocytes from 16 tg female mice were pooled. None of the tg
donor mice had developed spontaneous EAE. CD3+ T cells
were enriched by negative selection using a Mouse T cell
Enrichment Column (R&D Systems, Minneapolis, MN, USA)
and labeled with anti-CD3–FITC or anti-TCRb–FITC, antiCD4–APC and anti-CD8–PercP. Cells were sorted by FACSVantage SE (Becton Dickinson). The purity of sorted T cells
was 98–99%.
5-Bromo-2-deoxyuridine incorporation
Recent thymic emigrants were detected as described previously (29), with a modification. Briefly, mice were given
sterile drinking water containing 0.8 mg/ml 5-bromo-2-deoxyuridine (BrdU) (Sigma Chemical Co., St Louis, MO, USA),
which was changed daily. After 10 days, the mice were sacrificed and splenocyte suspensions were prepared. Cells
were surface stained with anti-TCRb, anti-CD4 and antiCD8, then washed and 2 3 106 cells were re-suspended in
BD PharMingenTM Stain Buffer. Cells were stained using
a BrdU Flow Kit (PharMingen) according to the manufacturer
and acquired by flow cytometry as described above. The
data were analyzed by FlowJo software.

Mice

In vitro proliferation assay

Generation of 4E3 (lines 1736 and 1740) and 5B6 tg mice
that express PLP 139–151-specific tg abTCRs have been
previously described (27). RAG-2-deficient mice were backcrossed onto the B10.S background for >10 generations.
4E3 and RAG-deficient tg mice were generated by crossing
the tg mice to the RAG2-deficient B10.S mice. PLP-deficient
mice (28) were obtained from K. Armin Nave (University of
Heidelberg, Heidelberg, Germany) and were backcrossed
onto the B10.S background. All the mice were housed under
specific pathogen-free conditions at the animal facility at the
Harvard Institutes of Medicine, Brigham and Women’s Hospital, Boston, MA, according to the animal protocol guidelines of standing committee of animals, Harvard Medical
School. Eight- to 12-week old female mice were used in all
the experiments.

Splenocytes (4 3 105) were cultured in 96-well plates together with three different concentrations of PLP 139–151
peptide (1, 10 and 100 mg/ml). Sorted T cell fractions
(3 3 104) were stimulated with PLP 139–151 peptide in the
presence of 5 3 105 irradiated splenocytes as APC or with
plate-bound anti-CD3 (5 lg) and soluble anti-CD28 (2 mg/ml)
mAbs. Cultures were pulsed with 1 lCi of [3H]thymidine
(New England Nuclear, MA, USA) after 48 h, and plates
were harvested and the filters were counted using a Wallac
scintillation counter 16 h later. The proliferative responses
were determined based on [3H]thymidine incorporation as
mean counts per minute in triplicate wells.

Antigens
The PLP 139–151 peptide (HSLGKWLGHPDKF) was synthesized using F-moc chemistry (QCB BioSource International,
Hopkinton, MA, USA). The peptide was HPLC purified and
its identity was confirmed by mass spectroscopy. The peptide was dissolved in sterile water before use.
Antibodies
Anti-CD4, anti-CD8, anti-CD3, anti-TCRb, anti-CD24 and
anti-CD69 mAbs were purchased from PharMingen (San

Cytokine measurement by ELISA
Supernatants obtained from splenic and fractionated T cell
cultures stimulated with PLP 139–151 peptide were collected
after 48 h of activation and stored at 70C until analysis.
Secretion of IL-2, IL-4, IL-10 and IFN-c was measured by
ELISA. Briefly, cytokine antibodies for IL-2, IL-4, IL-10 and
IFN-c were coated onto 96-well plates at a concentration of
1 mg/ml overnight. The plates were washed and treated with
blocking solution (Kierkegaard and Perry, Gaithersburg, MD,
USA), followed by incubation of culture supernatants overnight at 4C. The plates were subsequently washed and incubated with their corresponding biotinylated cytokinedetecting mAb (1 mg/ml) for 2 h (IL-2, JES6-A112 and
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JES6-5H4; IL-4, 11B11 and BVD6-24G2; IL-10, JES5-16E3
and SXC-1 and IFN-c, R4-6A2 and XMG1.2). The plates
were developed after adding avidin peroxidase and its substrate and read on a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA).

Table 1. Frequency of spontaneous EAE in 4E3 TCR tg mice,
line 1740

Adoptive transfer to induce EAE

N4
N5
N6

T cell subsets (CD3+, CD4+CD3hi and DN CD3hi) were isolated either by enrichment of CD3+ T from spleens and thymus of tg mice using mouse T cell enrichment columns by
negative selection (R&D Systems) or by flow cytometric sorting. Cells (5 3 106) were injected in PBS into RAG2-deficient
B10.S mice. The recipient mice were monitored for appearance of clinical signs of EAE and were scored on a 0–5
scale (1: limp tail, 2: hindlimb paresis, 3: complete hindlimb
paralysis, 4: forelimb paresis and 5: moribund).

Generation

SJL/J

B10.S

Incidencea

Severityb

Incidence

Severity

1/8 (13%)
9/15 (60%)
NAc

3
2.2
NA

3/7 (40%)
2/6 (30%)
4/17 (24%)

2
1
2

4E3 TCR tg mice on SJL/J and B10.S back-cross generations were
monitored regularly for signs of EAE for at least 6 months.
a
Number of tg mice with spontaneous EAE per total number of tg mice
in each generation are shown and frequencies of disease are given in
percentages (%). bSeverity is shown as mean peak disease severity.
c
NA, not applicable, the line could not be maintained.

We previously generated tg mice that express different rearranged abTCRs specific for PLP 139–151, i.e. 5B6 and 4E3
mice. The 4E3 TCR has a higher affinity for the PLP 139–
151/IAs complex than the 5B6 TCR (27). When these tg mice
were backcrossed onto the EAE-susceptible SJL/J background, 4E3 mice (line 1740) developed spontaneous EAE
with a higher frequency than 5B6 tg mice. The high incidence of fulminant disease resulted in the loss of this line
on the SJL/J background (Table 1). Another 4E3 line (1736)
also could not be maintained on the EAE-susceptible SJL/J
background (27). However, when 4E3 mice were backcrossed onto the EAE-resistant B10.S background, the frequency of spontaneous disease was significantly lower
reaching a steady-state level of 25% by the age of 6 months
(Table 1).

selection of tg CD4+ T cells. However, we found a 10- to 15fold increase in the percentage of DN cells among mature
(CD3hi) T cells compared with WT littermates (tg 4E3:
33.9 6 3.25%, WT: 2.25 6 0.36%, P < 0.01), while the percentage of CD4 single-positive (SP) thymocytes was proportionally decreased (Fig. 1A). There was, however, no
apparent difference in the percentage of either CD3hi or
CD3low double-positive (DP) T cells between tg and control
mice (Fig. 1A). Moreover, while the majority of DN T cells in
4E3 mice expressed high CD3 (Fig. 1A and B), the majority
of DP cells was CD3low similar to WT mice (Fig. 1A). This increase in percentage of DN CD3hi thymocytes with the proportional decrease of CD4+ T cells was specific to 4E3 tg
mice, since in another tg line (5B6), the percentages of DN
CD3hi cells were similar to those in WT littermates (tg 4E3:
33.9 6 3.25%, tg 5B6: 3.4 6 0.41%, WT: 2.25 6 0.36%,
P < 0.01), while the proportions of tg CD4 SP thymocytes
were increased (Fig. 1A and B). Although we observed
a slight increase in the percentage of DN T cells also on the
SJL/J background in 4E3 mice, this did not reach the magnitude of that observed on the B10.S background (data not
shown) (27). Since none of the 4E3 TCR tg lines could be
propagated on the SJL/J background, the rest of this paper
deals with the analysis of 4E3 TCR tg line on the resistant
background.
The high expression of CD3 on DN cells indicated that
these thymocytes had been positively selected and that they
do not represent thymocytes that are arrested at an early
stage of development due to transgenesis. In addition,
;16% of DN CD3hi cells expressed the CD69 molecule in
4E3 tg mice (16.08 6 0.7), while CD69 was undetectable on
DN cells of WT littermates (Fig. 1C). These data suggest that
in 4E3 tg B10.S mice, the DN CD3hi population contains
positively selected mature T cells (30).

4E3 tg B10.S mice demonstrate a high proportion of
CD4 CD8 (DN) CD3hi cells in the thymus and spleen

DN TCRb+ cells in the spleen of 4E3 tg mice are recent
thymic emigrants

There was no apparent difference in the size of thymus,
spleen and lymph nodes or in the absolute number of cells
in these organs between 4E3 mice and wild-type (WT) littermates, indicating that there was no gross clonal deletion of
tg T cells (data not shown). The percentage of CD3hi cells
and CD4/CD8 ratios were increased in the thymus of 4E3 tg
mice as compared with WT littermates, indicating positive

If DN CD3hi thymocytes are positively selected, they should
emigrate from the thymus. Indeed, the percentage of DN
TCRb+ T cells was increased up to 3-fold in the spleens of
4E3 tg mice compared with WT littermates (mean
5.8 6 0.26 versus 1.5 6 0.16%) (Fig. 2).
To determine if the peripheral tg DN T cells were generated in the thymus or by extrathymic maturation in the

Histopathology
Mice were sacrificed when they reached a score of 4 or
higher or when they began to recover from disease as indicated by no further increase in clinical score. Mice that did
not develop EAE were sacrificed between days 28 and 35
after immunization. Brain and spinal cords were removed
and fixed in 10% phosphate-buffered formalin. For histological assessment of inflammation, the brain and spinal cord
were embedded in paraffin and sections stained with Luxol
fast blue–hematoxylin and eosin stain. Meningeal and parenchymal inflammatory foci were counted by an observer
blinded to the clinical status of the animals.
Results
4E3 tg mice expressing a PLP 139–151-specific TCR do not
develop fulminant EAE on the resistant B10.S background
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Fig. 1. The percentage of DN CD3hi cells is increased in the thymus of PLP 139–151-specific TCR tg 4E3 mice. (A) Surface expression of CD4
and CD8 was examined on CD3hi thymocytes in female PLP 139–151-specific 4E3 tg and 5B6 tg mice and WT littermates. Representative data
are shown. (B) Surface expression of CD4 and CD8 was examined on CD3hi thymocytes as shown in (A) in 26 female PLP 139–151-specific 4E3
tg mice, 11 WT littermates and 5B6 tg mice. Percentage of DN CD3hi cells is shown. (C) The percentage of CD69+ DN thymocytes is shown in
a tg 4E3 mouse and WT littermate. Representative data of six separate experiments are shown.
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Fig. 2. The percentage of DN TCRb+ T cells is increased in the spleen of 4E3 TCR tg mice. (A) Surface expression of CD4 and CD8 was
examined on TCRb+ splenocytes in 14 female 4E3 tg mice and WT littermates. (B) Representative data are shown.

periphery, 4E3 mice and WT littermates were given daily
BrdU in the drinking water for 10 days. At the end of the labeling period, splenocytes were isolated and stained with
anti-TCRb, anti-CD4, anti-CD8 and anti-BrdU mAbs. It has
been shown that recent thymic emigrants are BrdUlow, in
contrast to the majority of peripheral T cells which are BrdUnegative resting cells and a small proportion of peripheral T
cells which are BrdUhi cycling cells (29). The majority of DN
TCRb+ cells (mean 74.2 6 6.8%) was BrdUlow in 4E3 mice,
suggesting that the majority of DN TCRb+ cells in the periphery was thymically derived and few if any proliferate in the

periphery (Fig. 3A). When the proportion of DN tg T cells
was examined among total thymic immigrants, 36% of the
BrdUlow TCRb+ cells were DN, in contrast to 5% in the WT
mice (36.1 6 4.5 versus 5 6 1.22%, P < 0.01). These data
indicate that DN thymocytes were exported to the periphery
in high numbers in 4E3 tg B10.S mice (Fig. 3B).
DN CD3hi and TCRb+ thymocytes and splenocytes are true
tg TCRab T cells
Currently, a clonotypic antibody is not available to detect
the expressed 4E3 tg TCR or its alpha and beta chains. To
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Fig. 3. Recent thymic emigrants in 4E3 TCR tg mice. (A) The percentage of recent thymic emigrants (BrdUlow) is shown in the DN TCRb+ subset
in a 4E3 tg mouse. Representative data of two different experiments with five mice in each are shown. (B) The percentage of TCRb+ DN and
CD4+ cells is shown in the subset of recent thymic emigrants (BrdUlow) in the spleen of a 4E3 tg mouse and WT littermate. The numbers in dot
plots indicate the percentage of DN and CD4 cells in the CD8 recent thymic emigrant populations (BrdUlow). Representative data of two
different experiments with five mice in each are shown.

preclude TCRcd and endogenous TCRab gene rearrangements, we generated 4E3 TCR tg mice on a RAG2-deficient
background by crossing the TCR tg mice with RAG-2-deficient B10.S mice. Cellular analysis in 4E3 and 4E3 RAG2deficient B10.S mice revealed that the percentages of DN
among CD3hi cells in the thymi of 4E3 tg mice with or without RAG-2 deficiency were comparable (mean 18.5 6 2.2%
and 20.7 6 2.8%) (Fig. 4A). In the spleens, the percentage
of DN TCRb+ cells was comparable or slightly increased in
RAG2-deficient compared with RAG2-intact 4E3 tg mice
(mean 7.5 6 0.5% and 5.7 6 0.7%) (Fig. 4B). These data indicate that the vast majority of mature DN T cells in thymus

and spleen of 4E3 TCR tg B10.S mice were positively selected and expressed the 4E3 abTCR exclusively.
DN TCRb+ tg T cells up-regulate CD4 following
TCR-mediated stimulation
The increased DN and a proportionate decrease of CD4+ T
cells in the thymus of 4E3 tg B10.S mice suggested that
CD4 co-receptor might be down-regulated resulting in the
conversion of CD4+ into DN CD3hi thymocytes (Fig. 1A). To
examine the possible down-modulation of CD4, we analyzed
expression of CD4 on DN T cells following T cell activation.
Splenocytes from 4E3 tg mice were stimulated with PLP

Double-negative T cells in PLP TCR transgenic mice
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Fig. 4. The percentage of DN T cells is increased in the thymus and spleen of RAG-2-deficient 4E3 TCR tg mice. (A) Surface expression of CD4
and CD8 was examined on CD3+ thymocytes in seven female 4E3 TCR tg mice and in 4E3 TCR tg mice on a RAG-2-deficient background.
Columns indicate percentage of DN CD3hi T cells and representative FACS data are shown. (B) Surface expression of CD4 and CD8 was
examined on TCRb+ splenocytes in seven female 4E3 TCR tg mice and in 4E3 TCR tg mice on RAG-2-deficient background. Columns indicate
percentage of DN TCRb+ T cells and representative FACS data are shown.
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139–151 peptide presented by irradiated antigen presenting
cells APC, and CD4 expression was analyzed by flow cytometry on TCRb+ T cells after 72 h. In unstimulated control cultures, only CD4+ and CD4 TCRb+ (DN) subsets were
detected. After stimulation with the PLP peptide, four different TCRb+ subsets could be distinguished based on the
expression level of CD4: CD4
(DN), CD4low, CD4+
and CD4hi (Fig. 5A). This suggested that both DN and
CD4+TCRb+ tg cells were able to modulate expression of
CD4 after stimulation with the PLP antigen. However, we
could not exclude the possibility that the CD4low subset
originated from CD4+ T cells by down-regulating the coreceptor. To distinguish between these two possibilities, we
sorted CD4+ and DN TCRb+ cells by flow cytometry from
spleens of female 4E3 mice, and then stimulated each subset separately with plate-bound anti-CD3 and soluble antiCD28 mAbs for 72 h. A subset of CD4 (DN) tg T cells upregulated the CD4 co-receptor upon activation (2.1 6 0.6%
versus mean 12.4 6 1.6%, P < 0.01). On the other hand,
we did not observe any down-regulation of the co-receptor
in the CD4+ tg T cell cultures (Fig. 5B). The up-regulation of
CD4 co-receptor upon stimulation suggested that DN tg T
cells retained the potential to modulate the expression of
the co-receptor and matured DN T cells might be generated
by down-modulation of CD4 on SP T cells.
DN T cells demonstrate blunted responses to CD4/MHC IIdependent TCR stimulation compared with CD4+ T cells
Our data indicate that tg CD3hi DN thymocytes with a modulated CD4 co-receptor rapidly migrate to the periphery and
constitutes a part of the peripheral repertoire in 4E3 tg
B10.S mice. Since CD4 has been shown to modulate the activation threshold of responding T cells (23, 31, 32), we hypothesized that CD4 down-regulation on tg T cells would
modulate the autoreactive response mediated by the highaffinity 4E3 TCR. To address this issue, DN TCRb+ and
CD4+ splenic T cells were isolated by cell sorting and stimulated with either PLP 139–151 or with plate-bound anti-CD3
and soluble anti-CD28 mAbs. Both subsets proliferated in
response to stimulation with the peptide, but the response
of DN tg T cells was significantly lower compared with that
of CD4+ T cells. In contrast, the two subsets proliferated
equally well to anti-CD3/CD28 stimulation. These data demonstrated that only the response of DN tg T cells to peptide
antigen were blunted (Fig. 6A). Consistent with these data,
reduced PLP 139–151-specific activation was also observed
in whole spleen cell cultures, where 33% of DN TCRb+ cells
compared with 70% of CD4+ T cells expressed the early activation marker CD69 in a 3-day culture (data not shown).
We also examined the cytokine production of sorted CD4+
and DN TCRb+ cells after stimulation with either PLP 139–
151 or anti-CD3/CD28. Both DN and CD4+ T cell subsets
produced Th1 cytokines (IL-2, IFN-c), but failed to produce
detectable amounts of IL-4 or IL-10 to either stimulus, indicating that DN T cells in 4E3 tg mice do not produce antiinflammatory cytokines or represent a regulatory subset
described previously (21). Consistent with the decreased
proliferative response, DN tg T cells produced less IL-2 and
IFN-c in response to PLP 139–151 compared with CD4+ tg
cells, while there was no difference in the production of

these cytokines after activation with the polyclonal stimulus
of anti-CD3/CD28 (Fig. 6B). Likewise, both T cell subsets
produced equal amounts of IFN-c after stimulation with phorbol myristate acetate/ionomycin (data not shown). These
data indicate that DN T cells showed no defect in proliferative or cytokine responses to CD4/MHC II-independent TCR
stimulation.
DN CD3hi tg cells induce EAE but are less encephalitogenic
than CD4+ tg T cells
To determine the in vivo response of 4E3 tg DN T cells to the
autoantigen, we examined the encephalitogenicity of these
cells upon adoptive transfer. We first tested whether tg SP
CD3+ T cells obtained from the thymus can induce EAE.
Sorted CD3high, CD4+ T cells obtained from thymus or
spleen induced EAE equally well upon adoptive transfer into
RAG-2-deficient B10.S mice (data not shown). Next, we
tested the encephalitogenic potential of DN CD3hi thymocytes by transferring 5 3 106 DN TCRb+ thymocytes into
RAG-2-deficient B10.S recipients. As a control, we also
transferred tg CD4+CD3hi cells into WT B10.S recipients.
The majority of recipients receiving CD4 SP thymocytes
(70%) developed severe disease (mean maximal score of
2.4 6 0.3) in 3 weeks after transfer. In contrast, transfer of
DN CD3hi thymocytes induced milder EAE (mean maximal
score of 1 6 0) in significantly fewer mice (25%) (Fig. 7 and
Table 2). There was no difference in the day of onset of disease between the two groups (Table 2). Adoptive transfer of
CD4+ tg T cells induced histological EAE in the CNS of all
mice (100%), while DN tg T cells induced histological EAE
in only a small portion of recipients (16%) (Table 3). We observed similar numbers of inflammatory foci in the meninges
and parenchyma exhibited within each group; however, significantly less inflammatory foci in recipients of DN 4E3 cells
compared with recipients of CD4+ tg T cells were detected
(Table 3). Based on these observations, we conclude that
DN T cells transfer EAE less efficiently into RAG-2-deficient
B10.S recipient mice than do CD4+ T cells indicating
a blunted antigen-specific response of DN tg T cells in vivo.
Thymic expression of PLP does not drive the generation of tg
DN CD3hi T cells
We have shown that a high frequency of DN CD3hi T cells is
selected in 4E3 TCR tg mice on the resistant B10.S background. These T cells respond poorly to PLP 139–151 and
consequently are weakly encephalitogenic. A possible explanation for these observations is that thymocytes bearing
the high-affinity 4E3 tg TCR down-modulate CD4 upon encounter of self-antigen in the thymus in order to avoid negative
selection. To address whether the expression of PLP in the
thymus is responsible for the generation of DN cells in 4E3 tg
B10.S mice, we crossed 4E3 TCR tg mice with PLP-deficient
mice (28) on the B10.S background and examined T cell
development in the thymus. As shown in Fig. 8(B), we found
that the frequency of DN cells present in 4E3 tg PLP-deficient
mice was not significantly different compared with 4E3 tg WT
littermate controls. Thus, the expression of PLP in the thymus
does not appear to play a role in the thymic down-modulation
of CD4 on 4E3 tg T cells on the B10.S background.
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Fig. 5. 4E3 TCR tg T cells up-regulate the CD4 co-receptor upon stimulation in vitro. (A) Splenocytes (4 3 105) of tg 4E3 mice were stimulated
with 50 lg ml 1 PLP 139–151 in vitro in the presence of irradiated antigen presenting cells. The expression of CD4 was examined on unstimulated
(left panel) and stimulated (right panel) TCRb+ cells by flow cytometry after 72 h. Representative data of three separate experiments are shown.
(B) CD4+TCRb+ (upper panel) and DN TCRb+ subsets (lower panel) were isolated by FACS sorting from spleens of 4E3 tg mice. T cells (3 3 104)
were stimulated with 5 lg plate-bound anti-CD3 and 2 lg ml 1 soluble anti-CD28 and the expression of CD4 was examined by flow cytometry
after 72 h. Representative data of three separate experiments are shown.
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Fig. 6. Proliferative response and cytokine production of sorted CD4+TCRb+ and DN TCRb+ subsets of 4E3 TCR tg mice. (A) CD4+TCRb+ and
DN TCRb+ subsets were sorted by FACS from spleens of 4E3 tg mice. T cells (3 3 104) were stimulated with 50 lg ml 1 PLP 139–151 in the
presence of 5 3 105 irradiated antigen presenting cells (left panel) or with 5 lg plate-bound anti-CD3 and 2 lg ml 1soluble anti-CD28 (right
panel). Proliferative responses were measured by incorporation of [3H]thymidine after 72 h. Data of three separate experiments are shown. (B)
The production of IL-2, IFN-c, IL-4 and IL-10 was examined by ELISA in the above cultures after 48-h stimulation with PLP 139–151 (upper panel)
or anti-CD3 and anti-CD28 (lower panel). Data of three separate experiments are shown.

Discussion
In this study, we show that TCR tg mice expressing a highaffinity TCR for the self myelin antigen PLP 139–151, when
bred on the resistant B10.S background, demonstrate a reduction in fulminant spontaneous EAE along with the appearance of a high proportion of DN tg T cells both in the

thymus and periphery. We show that the magnitude of DN
tg T cell responses to self-antigen PLP 139–151 in vitro and
in vivo are blunted in the absence of CD4, although the
responses to anti-CD3 are comparable to CD4+ tg T cells
in vitro. In addition, DN T cells can partly up-regulate the CD4
co-receptor upon activation, suggesting that CD4 was not lost
due to developmental block but is actively down-regulated.
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Table 2. Characterization of EAE induced by adoptive transfer of CD4+CD3hi or DN CD3hi thymocytes
Donor
CD4
DNl

Incidence
7/10
3/12

Incidence (%)

Mean onset (days)
a

60*
25

20.6 6 0.9
20 6 1.1

Mean maximum score

Mortality (%)

Recovery (%)

2.4 6 0.3*
160

14*
0

0
66*

EAE was induced by adoptive transfer of sorted CD4+CD3hi or DN CD3hi thymocytes into RAG-deficient B10.S mice and scored as described in
Methods. aSEM. *P < 0.05.

Table 3. Histologic EAE induced by adoptive transfer of CD4+CD3hi or DN CD3hi thymocytes
Donor

CD4
DN

Incidence

Incidence %

10/10*
2/12

Number of inflammatory foci (mean 6 SEM)

100*
16

Meninges

Parenchyma

Total

63.1 6 7.7*
29.9 6 19.7

65.5 6 12.7*
20.1 6 12.8

129.6 6 17.8*
50.8 6 30.7

EAE was induced by adoptive transfer of sorted CD4+CD3hi or DN CD3hi thymocytes into RAG-deficient B10.S mice. The number of
inflammatory foci was determined as described in Methods. *P < 0.05.
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Fig. 7. Induction of EAE with 4E3 TCR tg T cell subsets. Thymi of 16
female 4E3 TCR tg mice were pooled, and CD4+CD3hi and DN CD3hi
subsets were sorted by flow cytometry. T cells (5 3 106) of each
fraction were injected intravenously into RAG-deficient B10.S mice,
respectively. Mice were scored for clinical signs of EAE daily as
described in Methods. Data represent average daily scores of mice
(DN CD3hi: 3/12, CD4+CD3hi: 7/10) pooled from two independent
experiments (see Table 2).

These results suggest that the tg DN T cells originate from
CD4+ T cells by down-regulating the co-receptor and that
this modulation of co-receptor limits activation of T cells
expressing a high-affinity TCR for self-antigen, thereby preventing the development of spontaneous disease. However,
this thymic modulation of the CD4 co-receptor was independent from the expression of PLP 139–150.
Approximately 70% of DN TCRb+ cells were recent thymic
emigrants in 4E3 tg B10.S mice. Several lines of evidence
indicated that the majority of these cells were generated in
the thymus, not extrathymically and were positively selected.
First, the high percentage of DN tg T cells in the thymus and
spleen were proportional, and a decrease in the percentage
of DN T cells with aging in the thymus resulted in decrease
in the percentage of DN cells in the periphery (data not
shown). In addition, a proportional decrease in the percentage of CD4+ along with an increase of tg DN thymocytes
may suggest conversion of SP CD4 T cells into DN thymocytes. Second, the high expression of CD3 on DN thymo-

cytes and the partial expression of CD69 indicate that the
DN cells were positively selected in the thymus. Third, generation of DN T cells from DP thymocytes by active downregulation of CD4 and CD8 co-receptors (11, 14, 33–36)
was unlikely in 4E3 mice, since peripheral DN T cells could
up-regulate only CD4 but not CD8 following TCR-mediated
stimulation, and DN thymocytes were CD3hi while DP cells
expressed only low levels of CD3. Although tg DN thymocytes may also maturate without passing the DP stage and
up-regulate any co-receptors (37), it is unlikely that 4E3 DN
T cells preserved only the potential of expressing CD4 but
not CD8 upon proper stimulation in the periphery. Fourth,
modulation of CD4 also excluded the abortive expression of
CD4 as a result of tg dysgenesis. Gross clonal deletion of tg
CD4+ thymocytes was also unlikely, since there was no decrease in the number of T cells or in the percentage of DP
cells between tg mice and WT littermates. Finally, DN thymocytes were capable to mediate EAE upon adoptive transfer.
The magnitude of immune responses to PLP 139–151 was
blunted in the absence of CD4, although the responses to
anti-CD3 were comparable. There was no difference in the
expression level of TCR between CD4+ and DN tg T cells,
suggesting that the reduced response was not the result of
TCR modulation. Since 4E3 tg DN T cells responded to PLP
139–151 and produced significant amounts of IFN-c and IL-2,
DN tg TCRb+ cells are not anergic and likely lack those
regulatory properties that had been previously ascribed to
anergic and DN T cells (21, 22, 38). 4E3 DN T cells behaved like CD4+ tg T cells, except that they had a reduced
capacity to respond to self-antigen. In addition to the reduced response in vitro, the adoptive transfer of DN CD3hi
T cells induced less severe disease than the transfer of CD4
T cells, highlighting the significance of CD4 modulation
in vivo. This modulated expression of co-receptor could increase the activation threshold of tg T cells, thereby decreasing the incidence of spontaneous EAE in 4E3 B10.S mice.
Nevertheless, DN 4E3 T cells were encephalitogenic upon
adoptive transfer. Our data also imply that the high affinity of
the 4E3 TCR could be a crucial factor in the generation of
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Fig. 8. DN CD3hi cells in the thymus of 4E3 tg PLP-deficient mice. Left panels: CD4 and CD8 expression profile of thymocytes from 4E3 tg WT
and 4E3 tg PLP-deficient littermates. Right panels: expression of CD3 on DN cells (closed histogram) relative to DP cells (open histogram). A total
of four mice were analyzed. Representative data are shown.

DN T cells. Another PLP 139–151-specific TCR 5B6 has
a lower affinity for the antigen/MHC II than the 4E3 TCR (10)
and 5B6 TCR on the B10.S background have no increase in
the percentage of DN T cells compared with WT littermates.
Altered activation thresholds have been previously shown in
studies of tg expression of antigen together with high-affinity
TCR, and after repeated stimulation with antigen in vitro (11,
21–23, 31, 32, 37–40). It should also be noted that the original 4E3 T cell clone had a non-functional CD4 co-receptor, indicating that such modulation of CD4 might also have been
responsible for T cells bearing this high-affinity TCR exiting
the thymus without deletion (27). Similar increases in DN tg
T cells have been previously described in other TCR tg mice
and in lpr/gld mice (21, 22, 35, 38, 41, 42) and in human
lymphoproliferative disorders and systemic lupus erythematosus (SLE) (43, 44). In these cases, modulation of the CD4
co-receptor as a result of exposure to self-ligands should be
also considered as a mechanism for peripheral tolerance,
particularly in lpr/gld mice and SLE in which autoreactive T
cells with high-affinity TCR may not be deleted due to their
defect in apoptosis.
Since mice 4E3 tg mice died on the SJL/J background
very early due to fulminant disease, the lines could not be
maintained, so we were not able to directly compare 4E3 tg
SJL/J and B10.S mice. However, our previous data indicated
no such increase in the number of 4E3 tg DN T cells in SJL/J

as observed in B10.S mice, suggesting that the high number
of tg DN T cells might be indeed related to the resistant
background (27). Since we have previously shown that differential thymic expression of thymic PLP may influence the
frequency of PLP-specific T cells and susceptibility to autoimmunity (4), we considered the possibility that higher expression of PLP in the thymus of B10.S mice along with
a high-affinity tg TCR may induce modulation of CD4. However, backcrossing the 4E3 B10.S tg mice onto a PLPdeficient background did not decrease the percentage of
thymic DN T cells, thus factors other than thymic expression
of autoantigen may influence the modulation of CD4. While
thymic expression of PLP antigen does not seem to influence the co-receptor modulation, the TCR signal might be
important. Two different lines bearing the 4E3 TCR exhibited
high number of DN T cells, while the percentage of DN T
cells was not significantly increased in the case of another
tg PLP-specific TCR, 5B6, which has a lower affinity for PLP
139–151. Thus, while cross-reactivity of the 4E3 PLP-specific
TCR with other thymic antigens can be one possible mechanism responsible to the modulated expression of CD4,
strength or duration of TCR signals and transcriptional regulation of co-receptors similar to differentiation of DP into SP
T cells may also play role (45). In any case, down-modulation
of CD4 on tg T cells resulted in a reduced response to the
autoantigen in the periphery in vitro and in vivo.

Double-negative T cells in PLP TCR transgenic mice
In summary, our data indicate that highly autoreactive T
cells can down-regulate the CD4 co-receptor in the thymus
on a resistant genetic background when there is a large
autoreactive repertoire. This modulation of CD4, irrespective
of the expression of PLP 139–150 in the thymus, can result
in tolerance to self-antigen in the periphery, thereby preventing or reducing the frequency of spontaneous autoimmune
disease.
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